Trv Gp Iii, LLC Fulcrum Therapeutics, Inc. Transaction History

Trv Gp Iii, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.01 - $8.35 $10 Million - $16.7 Million	-2,000,000 Reduced 50.48%	1,962,202 $14.3 Million
Q4 2021 Feb 14, 2022	SELL	$14.0 - $28.44 $14 Million - $28.4 Million	-1,000,000 Reduced 20.15%	3,962,202 $70.1 Million
Q3 2021 Nov 05, 2021	SELL	$7.28 - $30.97 $7.28 Million - $31 Million	-1,000,000 Reduced 16.77%	4,962,202 $140 Million
Q3 2019 Nov 04, 2019	BUY	$6.64 - $14.89 $39.6 Million - $88.8 Million	5,962,202 New	5,962,202 $39.6 Million

134

52.8M

3.08M

316K

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $192M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Trv Gp Iii, LLC, based on Form 13F filings with the SEC.

Stay updated on Trv Gp Iii, LLC with notifications on news.